Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 01/23/2025

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Delaware Healthcare Fund

DLHAX | Fund

$24.42

$776 M

13.47%

$3.29

1.25%

Vitals

YTD Return

2.8%

1 yr return

9.1%

3 Yr Avg Return

7.2%

5 Yr Avg Return

6.7%

Net Assets

$776 M

Holdings in Top 10

47.8%

52 WEEK LOW AND HIGH

$24.1
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.25%

SALES FEES

Front Load 5.75%

Deferred Load N/A

TRADING FEES

Turnover 1.00%

Redemption Fee N/A

Min Investment

Standard (Taxable)

$1,000

IRA

$250

Fund Classification

Fund Type

Open End Mutual Fund

Name

As of 01/23/2025

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Delaware Healthcare Fund

DLHAX | Fund

$24.42

$776 M

13.47%

$3.29

1.25%

DLHAX - Profile

Distributions

  • YTD Total Return 2.8%
  • 3 Yr Annualized Total Return 7.2%
  • 5 Yr Annualized Total Return 6.7%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.20%
DIVIDENDS
  • Dividend Yield 13.5%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Delaware Healthcare Fund
  • Fund Family Name
    Delaware Funds by Macquarie
  • Inception Date
    Sep 28, 2007
  • Shares Outstanding
    N/A
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Liu-Er Chen

Fund Description

Under normal circumstances, the Fund will invest at least 80% of its assets, plus the amount of any borrowings for investment purposes, in the equity securities of healthcare companies, meaning companies that develop, produce, or distribute products or services related to the healthcare or medical industries and derive a substantial portion, that is, more than 50%, of their sales from products and services in the healthcare industry (80% policy). These products and services include, but are not limited to, pharmaceutical companies, biotechnology companies, medical device and supply companies, managed care companies, and healthcare information and service providers. The Fund invests in US and non-US companies across all market capitalizations. The Fund may invest up to 50% of its total assets in non-US companies. The Fund may also invest up to 25% of its total assets in companies located in emerging markets. The Fund is a nondiversified fund.

The Manager may permit its affiliate, Macquarie Investment Management Global Limited (MIMGL), to execute Fund security trades on behalf of the Manager. The Manager may also seek quantitative support from MIMGL.

The Fund’s 80% policy is nonfundamental and may be changed without shareholder approval. Fund shareholders would be given at least 60 days’ notice prior to any such change.

Read More

DLHAX - Performance

Return Ranking - Trailing

Period DLHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.8% -4.7% 15.2% 87.90%
1 Yr 9.1% -9.5% 25.3% 26.75%
3 Yr 7.2%* -16.5% 14.6% 17.76%
5 Yr 6.7%* -9.3% 11.6% 42.95%
10 Yr 9.1%* -1.9% 13.3% 4.35%

* Annualized

Return Ranking - Calendar

Period DLHAX Return Category Return Low Category Return High Rank in Category (%)
2024 -4.2% -28.2% 19.2% 66.88%
2023 -1.9% -12.6% 19.0% 80.89%
2022 -9.3% -53.9% 3.2% 26.97%
2021 -0.5% -39.6% 24.2% 57.24%
2020 5.3% -13.6% 178.2% 81.88%

Total Return Ranking - Trailing

Period DLHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.8% -4.7% 15.2% 87.90%
1 Yr 9.1% -9.5% 25.3% 26.75%
3 Yr 7.2%* -16.5% 14.6% 17.76%
5 Yr 6.7%* -9.3% 11.6% 42.95%
10 Yr 9.1%* -1.9% 13.3% 4.35%

* Annualized

Total Return Ranking - Calendar

Period DLHAX Return Category Return Low Category Return High Rank in Category (%)
2024 8.5% -28.2% 19.2% 9.55%
2023 4.2% -12.6% 19.0% 46.50%
2022 -1.3% -53.9% 3.7% 9.21%
2021 5.3% -33.9% 26.0% 69.08%
2020 11.1% -0.7% 180.6% 90.60%

NAV & Total Return History

DLHAX - Holdings

Concentration Analysis

DLHAX Category Low Category High DLHAX % Rank
Net Assets 776 M 7.21 M 45.7 B 53.50%
Number of Holdings 107 25 430 33.76%
Net Assets in Top 10 400 M 2.55 M 23.9 B 51.59%
Weighting of Top 10 47.84% 18.5% 78.1% 41.40%

Top 10 Holdings

  1. Eli Lilly Co 9.33%
  2. Regeneron Pharmaceuticals Inc 5.91%
  3. UnitedHealth Group Inc 5.32%
  4. Amgen Inc 4.63%
  5. Merck Co Inc 4.53%
  6. Pfizer Inc 3.97%
  7. Elevance Health Inc 3.92%
  8. Boston Scientific Corp 3.81%
  9. Chugai Pharmaceutical Co Ltd 3.35%
  10. AbbVie Inc 3.07%

Asset Allocation

Weighting Return Low Return High DLHAX % Rank
Stocks 		93.48% 89.92% 106.13% 86.62%
Cash 		6.52% 0.00% 33.01% 14.65%
Preferred Stocks 		0.00% 0.00% 7.86% 75.16%
Other 		0.00% -22.99% 23.24% 68.79%
Convertible Bonds 		0.00% 0.00% 0.37% 65.79%
Bonds 		0.00% 0.00% 12.39% 75.80%

Stock Sector Breakdown

Weighting Return Low Return High DLHAX % Rank
Healthcare 		99.04% 59.26% 100.00% 70.39%
Communication Services 		0.69% 0.00% 9.11% 1.97%
Financial Services 		0.20% 0.00% 1.60% 14.47%
Basic Materials 		0.07% 0.00% 7.16% 31.58%
Utilities 		0.00% 0.00% 0.00% 61.84%
Technology 		0.00% 0.00% 22.69% 63.82%
Real Estate 		0.00% 0.00% 5.89% 63.16%
Industrials 		0.00% 0.00% 7.02% 63.16%
Energy 		0.00% 0.00% 0.00% 61.84%
Consumer Defense 		0.00% 0.00% 25.73% 67.76%
Consumer Cyclical 		0.00% 0.00% 1.92% 63.16%

Stock Geographic Breakdown

Weighting Return Low Return High DLHAX % Rank
US 		79.92% 68.81% 104.41% 78.34%
Non US 		13.56% 0.00% 28.83% 20.38%

DLHAX - Expenses

Operational Fees

DLHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.25% 0.08% 50.00% 40.13%
Management Fee 0.83% 0.03% 50.00% 72.61%
12b-1 Fee 0.25% 0.00% 1.00% 42.86%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

DLHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 3.50% 5.75% 37.50%
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

DLHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

DLHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 1.00% 1.00% 238.00% 1.50%

DLHAX - Distributions

Dividend Yield Analysis

DLHAX Category Low Category High DLHAX % Rank
Dividend Yield 13.47% 0.00% 6.24% 1.91%

Dividend Distribution Analysis

DLHAX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Quarterly Annual

Net Income Ratio Analysis

DLHAX Category Low Category High DLHAX % Rank
Net Income Ratio 0.20% -2.54% 1.85% 26.67%

Capital Gain Distribution Analysis

DLHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

DLHAX - Fund Manager Analysis

Managers

Liu-Er Chen

Start Date

Tenure

Tenure Rank

Sep 28, 2007

14.68

14.7%

Liu-Er Chen, CFA, Senior Vice President, Chief Investment Officer — Emerging Markets and Healthcare, is a Portfolio Manager in Delaware Investments Fund Advisers, a series of Macquarie Investment Management Business Trust. Mr. Chen heads the firm's global Emerging Markets team. Prior to joining Macquarie Investment Management (MIM) in September 2006 in his current position, Mr. Chen spent nearly 11 years at Evergreen Investment Management Company, where he most recently served as Managing Director and Senior Portfolio Manager. Mr. Chen began his career at Evergreen in 1995 as an analyst.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 8.04 0.25

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.